New Human “Pangenome” Reference Released
The comprehensive collection of genome sequences aims to better and accurately capture human diversity
Researchers have released a new high-quality collection of reference human genome sequences that captures substantially more diversity from different human populations than what was previously available. The work—published recently in Nature—was led by the Human Pangenome Reference Consortium (HPRC)—an international group funded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH).
The new “pangenome” reference includes genome sequences of 47 people, with the researchers pursuing the goal of increasing that number to 350 by mid-2024. With each person carrying a paired set of chromosomes, the current reference actually includes 94 distinct genome sequences, with a goal of reaching 700 distinct genome sequences by the completion of the project.
To understand the small genomic differences in individuals, scientists create reference human genome sequences for use as a “standard”—a digital amalgamation of human genome sequences that can be used as a comparison to align, assemble, and analyze other human genome sequences.
Limitations of the original human genome sequence
The original reference human genome sequence is nearly 20 years old and has been regularly updated as technology advances and researchers fix errors and discover more regions of the human genome. However, it is fundamentally limited in its representation of the diversity of the human species as it consists of genomes from only about 20 people and most of the reference sequence is from only one person.
“Everyone has a unique genome, so using a single reference genome sequence for every person can lead to inequities in genomic analyses,” said Adam Phillippy, PhD, senior investigator in the computational and statistical genomics branch within NHGRI’s Intramural Research Program and a co-author of the main study. “For example, predicting a genetic disease might not work as well for someone whose genome is more different from the reference genome.”
The current reference human genome sequence has gaps that reflect missing information, especially in areas that were repetitive and hard to read. Recent technological advances such as long-read DNA sequencing helped researchers fill in those gaps to create the first complete human genome sequence. This complete human genome sequence, released last year as part of the NIH-funded Telomere-to-Telomere (T2T) consortium, is incorporated into the current pangenome reference. In fact, many of the T2T researchers are also members of the HPRC.
Features of the new human pangenome reference
Using advanced computational techniques to align the various genome sequences, the researchers constructed a new human pangenome reference with each assembly in the pangenome covering more than 99 percent of the expected sequence with more than 99 percent accuracy. It also builds upon the previous reference genome sequence—which was single and linear—adding over 100 million new bases in DNA and representing many different versions of the human genome sequence at the same time. This gives researchers a wider range of options for using the pangenome in analyzing other human genome sequences.
The total cost of supporting the work of the Human Pangenome Reference Consortium is projected to be about $40 million over five years, which includes efforts to create the human pangenome reference, improve DNA sequencing technology, operate a coordinating center, conduct outreach, and create resources for the research community to use the pangenome reference.
“By using the pangenome reference, we can more accurately identify larger genomic variants called structural variants,” said Mobin Asri, a PhD student at the University of California Santa Cruz and co-first author of the paper. “We are able to find variants that were not identified using previous methods that depend on linear reference sequences."
Structural variants can involve thousands of bases. Until now, researchers have been unable to identify the majority of structural variants that exist in each human genome using short-read sequencing due to the bias of using a single reference sequence.
Significance of the new human pangenome reference
“The human pangenome reference will enable us to represent tens of thousands of novel genomic variants in regions of the genome that were previously inaccessible,” said Wen-Wei Liao, a PhD student at Yale University and co-first author of the paper. “With a pangenome reference, we can accelerate clinical research by improving our understanding of the link between genes and disease traits.”
Many of the individuals whose genomes were sequenced for constructing the new human pangenome reference were originally recruited as part of the 1,000 Genomes Project, a collaborative and international effort funded in part by the NIH that aimed to improve the catalog of genomic variants in diverse populations. Because the human pangenome reference is a work in progress, international researchers from the HPRC continue to add more genome sequences to consistently improve the quality of the pangenome reference.
“Basic researchers and clinicians who use genomics need access to a reference sequence that reflects the remarkable diversity of the human population. This will help make the reference useful for all people, thereby helping to reduce the chances of propagating health disparities,” said Eric Green, MD, PhD, director of the NHGRI. “Creating and enhancing a human pangenome reference aligns with NHGRI’s goal of striving for global diversity in all aspects of genomics research, which is crucial to advance genomic knowledge and implement genomic medicine in an equitable way.”
In line with this effort, the HPRC includes an embedded ethics group that is working to anticipate challenging issues and help guide informed consent, prioritize the study of different samples, explore possible regulatory issues pertaining to clinical adoption, and work with international and Indigenous communities to incorporate their genome sequences in these broader efforts.
- This press release was originally published on the National Institutes of Health website